Volume 2 Supplement 2

Abstracts from the 1st Immunotherapy of Cancer Conference (ITOC1)

Open Access

P26. Cancer associated fibroblasts contribute to the immune suppression of breast cancer by augmentation of the inflammatory products

  • L Langroudi1,
  • ZM Hasan1,
  • M Soleimani2 and
  • SMM Hashemi3
Journal for ImmunoTherapy of Cancer20142(Suppl 2):P17

https://doi.org/10.1186/2051-1426-2-S2-P17

Published: 12 March 2014

Background

The supporting stroma of breast cancer is believed to support the growth and metastasis of cancer cells and are responsible for suppressing anti-cancer immune responses. In this regard we attempted to isolate and characterise the cancer associated fibroblasts (CAFs) of murine model of spontaneously developed breast cancer.

Methods

CAFs were isolated by explants culture of tumour tissue. The Fibroblast activated protein-alpha( FAP-α)-positive fibroblasts were co-cultured with splenocytes where the splenocyte proliferation and production of inflammatory and regulatory cytokines were assessed by ELISA. Also the inflammatory enzymes iNOS and the production of matrix metaloproteinases 2 and 9 by these cells were evaluated using Real-Time PCR.

Results

Findings indicated enhanced in vitro immune suppression in co-cultures of CAF and splenocyte. Additionally, increased regulatory cytokine and inflammatory mediators was observed.

Conclusion

The secretory profile of these cells, as the supporting matrix, is a massive physical and immune barrier to anti-cancer immune therapy. Therefore it is proposed for enhancing the effect of therapy must take into acount the contribution of cancer associated fibroblasts on the chronic inflammatory microenvironment of breast cancer.

Authors’ Affiliations

(1)
Immunology, Tarbiat Modares University
(2)
Haematology, Tarbiat Modares University
(3)
Stem Cell Technology Center, Stem Cell Biology

Copyright

© Langroudi et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement